Expert Talk | Deodorants & Antiperspirants

Deodorants and antiperspirants are among the most widely used personal care products, making product quality, safety, performance, and regulatory compliance essential considerations for brands, manufacturers, and distributors.

Join Eurofins Cosmetics & Personal Care for this two-part Expert Talk series exploring key considerations throughout the testing and evaluation of deodorants and antiperspirants, from analytical and regulatory requirements to clinical safety, efficacy, and claim substantiation.

Part 1: Quality, Compliance & Analytical Testing

Monday, November 2, 2026 | 11:00 AM EDT

This session will focus on the analytical and regulatory aspects of deodorants and antiperspirants, covering:

• Product types and key quality risks
• Analytical testing requirements
• Regulatory considerations in the United States and Canada
• Method validation, verification, and transfer, and what clients should expect

Register for Part 1

Part 2: Clinical Evaluation of Safety & Performance

Monday, November 9, 2026 | 11:00 AM EDT

The second session will focus on clinical evaluation and the approaches used to assess product safety and demonstrate performance, including:

• Clinical safety assessments
• Efficacy testing
• Claim substantiation
• Study designs that support product performance claims and consumer expectations

Register for Part 2

Register for one or both sessions to gain practical insights from Eurofins experts into the testing strategies that can help support the safety, quality, performance, and compliance of deodorant and antiperspirant products.